BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11346902)

  • 1. [Fulminant hepatocellular necrosis following administration of docetaxel].
    Tomassini E; Muhizi J; al Raheb K; Steinbach G; Bemer M; Platini C
    Presse Med; 2001 Apr; 30(13):634. PubMed ID: 11346902
    [No Abstract]   [Full Text] [Related]  

  • 2. Fatal herpes simplex virus hepatitis complicating chemotherapy with weekly docetaxel.
    Hofer S; Hunziker S; Tornillo L; Ludwig CU
    Ann Oncol; 2003 Feb; 14(2):340. PubMed ID: 12562665
    [No Abstract]   [Full Text] [Related]  

  • 3. Docetaxel-induced radiation recall dermatitis and successful rechallenge without recurrence.
    Camidge DR; Kunkler IH
    Clin Oncol (R Coll Radiol); 2000; 12(4):272-3. PubMed ID: 11005698
    [No Abstract]   [Full Text] [Related]  

  • 4. Docetaxel (Taxotere) for advanced breast cancer.
    Med Lett Drugs Ther; 1996 Sep; 38(984):87-8. PubMed ID: 8828520
    [No Abstract]   [Full Text] [Related]  

  • 5. Docetaxel.
    Leahy M; Howell A
    Br J Hosp Med; 1997 Feb 19-Mar 4; 57(4):141-4. PubMed ID: 9166374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paclitaxel and docetaxel. Innovation, but at what cost?
    Lønning PE
    Pharmacoeconomics; 1995 Jul; 8(1):1-4. PubMed ID: 10155597
    [No Abstract]   [Full Text] [Related]  

  • 7. Severe syndrome of inappropriate antidiuretic hormone secretion with docetaxel treatment in metastatic breast cancer.
    Langer-Nitsche C; Lück HJ; Heilmann M
    Acta Oncol; 2000; 39(8):1001. PubMed ID: 11206991
    [No Abstract]   [Full Text] [Related]  

  • 8. Reversible life-threatening encephalopathy in the absence of hepatic failure following conventional doses of docetaxel.
    Guglani S; Farrugia D; Elsdon M; Parmar M; Owen JR
    Clin Oncol (R Coll Radiol); 2003 May; 15(3):160-1. PubMed ID: 12801056
    [No Abstract]   [Full Text] [Related]  

  • 9. Docetaxel. A review of its role in breast cancer treatment.
    Antoine EC; Rixe O; Auclerc G; Weil M; Khayat D
    Am J Clin Oncol; 1997 Aug; 20(4):429-32. PubMed ID: 9256905
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful docetaxel rechallenge with cromoglycate after major sensitivity reactions.
    Westermann AM; ten Bokkel Huinink WW; Rodenhuis S
    Ann Oncol; 1996 Jan; 7(1):104. PubMed ID: 9081381
    [No Abstract]   [Full Text] [Related]  

  • 11. [Current developments in use of docetaxel (taxotere) in gynecologic oncology].
    Jackisch C
    Med Klin (Munich); 1998 Sep; 93 Suppl 3():4-15. PubMed ID: 9796219
    [No Abstract]   [Full Text] [Related]  

  • 12. Taxoids: new weapons against cancer.
    Nicolaou KC; Guy RK; Potier P
    Sci Am; 1996 Jun; 274(6):94-8. PubMed ID: 8643952
    [No Abstract]   [Full Text] [Related]  

  • 13. Response to dexamethasone in patients with fluid retention after docetaxel.
    Chan S; Winterbottom L; Gardner S
    Lancet; 1996 May; 347(9013):1486-7. PubMed ID: 8676655
    [No Abstract]   [Full Text] [Related]  

  • 14. Docetaxel-induced subungual hemorrhage.
    Vanhooteghem O; André J; Vindevoghel A; Vandenbossche L; Vandeveire A; Song M
    Dermatology; 1997; 194(4):419-20. PubMed ID: 9252781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Low-dose weekly administration of docetaxel for metastatic breast cancer].
    Kimijima I; Watanabe T; Sagara H; Ohtake T; Tsuchiya A; Abe R
    Gan To Kagaku Ryoho; 1999 Jun; 26(7):995-9. PubMed ID: 10396330
    [No Abstract]   [Full Text] [Related]  

  • 16. Ataxia following docetaxel infusion.
    Hofstra LS; van der Graaf WT; de Vries EG; Haaxma-Reiche H; Willemse PH
    Ann Oncol; 1997 Aug; 8(8):812-3. PubMed ID: 9332695
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical picture: nail changes secondary to docetaxel.
    Wasner G; Hilpert F; Baron R; Pfisterer J
    Lancet; 2001 Mar; 357(9260):910. PubMed ID: 11289346
    [No Abstract]   [Full Text] [Related]  

  • 18. Nail changes secondary to docetaxel (Taxotere).
    Correia O; Azevedo C; Pinto Ferreira E; Braga Cruz F; Polónia J
    Dermatology; 1999; 198(3):288-90. PubMed ID: 10393455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paclitaxel and docetaxel in breast and ovarian cancer.
    Drug Ther Bull; 1997 Jun; 35(6):43-6. PubMed ID: 9282422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation of seborrheic keratoses due to docetaxel treatment.
    Chu CY; Yang CH; Chiu HC
    Acta Derm Venereol; 2001; 81(4):316-7. PubMed ID: 11720193
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.